News

Radioactive material from America's first atomic bomb experiments has been turned into a surprising treatment for multiple ...
Radioactive material from America's first atomic bomb experiments has been turned into a surprising treatment for multiple ...
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to ...
BRUSSELS, Belgium I July 24, 2025 I Precirix, a clinical-stage biopharmaceutical company focused on developing innovative targeted radiopharmaceutical ...
Curadh MTR Inc. and Alpha Fusion, Inc. are set to showcase advances in cancer treatment using Astatine-211 (At-211) ...
STUTTGART, Germany I July 24, 2025 I La Merie Publishing released its newest product entitled: Folate Receptor alpha (FRα) Targeted Therapy: a Competitor ...
Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...
The former headquarters of the Manhattan Project, where the world's first atomic bomb was created, is now turning nuclear ...
Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...
Anixa Biosciences' breast cancer vaccine elicited targeted immune responses in 70% of patients. Click here to read an ...